Canada markets closed

Inovio Pharmaceuticals Inc. (GBM.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
7.14-0.19 (-2.59%)
At close: 04:14PM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-124,938
-135,117
-279,818
-303,659
-166,411
Depreciation & amortization
3,111
3,504
5,496
4,731
4,628
Deferred income taxes
-
-32.046
0
0
0
Stock based compensation
9,789
11,072
22,555
26,337
15,648
Change in working capital
-12,589
-10,260
19,834
50,351
-71,072
Accounts receivable
2,484
9,333
-3,706
11,032
-17,015
Accounts Payable
-8,411
-45,989
32,607
26,141
3,251
Other working capital
-116,521
-124,686
-217,185
-216,940
-179,500
Other non-cash items
20.159
155.814
186.977
858.644
2,364
Net cash provided by operating activites
-116,461
-124,366
-216,215
-215,709
-177,979
Cash flows from investing activities
Investments in property, plant and equipment
-59.493
-320.898
-969.153
-1,231
-1,521
Acquisitions, net
-
0
-2,000
0
-1,400
Purchases of investments
-132,795
-203,475
-248,529
-348,953
-156,217
Sales/Maturities of investments
246,445
284,933
361,084
174,840
62,991
Other investing activites
-
-
-
-
-2,775
Net cash used for investing activites
113,739
87,356
109,586
-175,344
-58,796
Cash flows from financing activities
Common stock issued
10,687
5,462
82,955
209,441
454,486
Other financing activites
-216.19
-466.646
-1,398
-4,611
-1,648
Net cash used privided by (used for) financing activities
-5,944
4,995
81,841
211,499
465,280
Net change in cash
-8,636
-32,018
-24,814
-179,584
228,532
Cash at beginning of period
28,238
46,329
71,144
250,728
22,196
Cash at end of period
19,571
14,311
46,329
71,144
250,728
Free Cash Flow
Operating Cash Flow
-116,461
-124,366
-216,215
-215,709
-177,979
Capital Expenditure
-59.493
-320.898
-969.153
-1,231
-1,521
Free Cash Flow
-116,521
-124,686
-217,185
-216,940
-179,500